Stillbirth or preterm birth linked to risk of blood clots

Article

Stillbirth or preterm birth may dramatically increase a woman’s risk of developing a blood clot immediately postpartum, according to the results of a large, population-based study appearing on the website of Blood, the journal of the American Society of Hematology (ASH).

 

Stillbirth or preterm birth may dramatically increase a woman’s risk of developing a blood clot immediately postpartum, according to the results of a large, population-based study appearing on the website of Blood, the journal of the American Society of Hematology (ASH).

The UK researchers who conducted the study found that venous thromboembolism (VTE) risk varies modestly by recognized factors during the antepartum period. However, they found that women who had experienced stillbirths, preterm births, obstetric hemorrhage, caesarean delivery, medical co-morbidities, or had a body mass index ≥30kg/m2 were at much higher risk of VTE following delivery.

The researchers reviewed data from more than 375,000 pregnancies in women aged 15 to 44 between January 1995 and July 2009.

The researchers discovered a significant correlation in the postpartum period between VTE risk and stillbirth (a 6-fold increased risk of VTE compared with women who did not have a stillbirth, IRR 6.2), a risk factor that is not currently addressed in VTE risk assessment guidelines. The researchers also determined other factors that led to an increased risk of VTE, including 3 or more previous births (IRR 2.07), preterm birth (prior to 37 weeks gestation, IRR 2.69), and obstetric hemorrhage (IRR 2.89). 

“Preventing VTE in pregnancy remains a challenging topic for clinicians since there is still disagreement as to which clinical, lifestyle, and socio-demographic factors qualify women as high-risk, and data are lacking about the relative impact of those factors on their risk of VTE,” said author Matthew Grainge, PhD, in an ASH press release. “Moreover, many studies have made the incorrect assumption that any risk factors identified have a similar impact on VTE rates in both pregnant women and new moms.”

Related Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
© 2024 MJH Life Sciences

All rights reserved.